There is no single “best” medicine for the heart. The right medication depends entirely on what’s threatening yours, whether that’s high blood pressure, high cholesterol, heart failure, or recovery after a heart attack. But a handful of drug classes have decades of evidence showing they prevent heart attacks, strokes, and early death. Here’s what each one does and who benefits most.
Blood Pressure Medications
Uncontrolled blood pressure is the leading modifiable risk factor for heart disease, and the 2025 guidelines from the American Heart Association and American College of Cardiology identify four first-line drug classes with strong evidence for lowering blood pressure and preventing cardiovascular events: thiazide-type diuretics (water pills), calcium channel blockers, ACE inhibitors, and ARBs. All four have been shown to reduce heart attacks and strokes compared to placebo.
ACE inhibitors and ARBs work similarly. They block a hormone system that tightens blood vessels and raises blood pressure. A large multinational study found that ARBs are equally effective as ACE inhibitors but cause fewer side effects, particularly the persistent dry cough, swelling reactions, and digestive problems that sometimes accompany ACE inhibitors. For that reason, many clinicians now favor ARBs as the starting choice.
If your blood pressure is only mildly elevated (stage 1, starting at 130/80), guidelines suggest trying lifestyle changes for three to six months first. If it stays elevated, or if your 10-year cardiovascular risk is above 10%, medication is recommended. For higher blood pressure readings (stage 2, at 140/90 or above), the current recommendation is to start two medications from different classes right away, ideally combined into a single pill to make daily adherence easier.
Statins for Cholesterol
Statins remain the most widely prescribed heart medications in the world, and their track record is hard to argue with. In pooled data from large prevention trials involving more than 85,000 people, statin therapy reduced the risk of heart attack by 33%, stroke by 22%, and death from any cause by 8%. These numbers come from people who had never yet had a cardiovascular event, meaning statins were being used purely as prevention.
Statins work by slowing your liver’s production of cholesterol, which forces it to pull LDL (“bad” cholesterol) out of your bloodstream. Lower LDL means less plaque buildup in your arteries over time. For people who can’t tolerate statins or whose cholesterol doesn’t drop enough, a newer class of injectable medications called PCSK9 inhibitors can cut LDL levels by over 50%. In one trial of statin-intolerant patients, these drugs lowered an average LDL of 193 mg/dL by 53 to 56 percent, far outperforming older alternatives.
An important nuance: statins work even better when combined with a heart-healthy eating pattern. A study tracking cardiovascular patients found that people who both took statins and followed a Mediterranean-style diet had dramatically lower rates of death from heart disease than those doing neither. The combination produced benefits that were greater than what you’d expect from adding each one separately. Diet and medication aren’t competing strategies. They amplify each other.
SGLT2 Inhibitors for Heart Failure
Originally developed for type 2 diabetes, SGLT2 inhibitors have turned out to be one of the most significant advances in heart medicine in recent years. These drugs help the kidneys flush out excess sugar and fluid, which reduces the workload on the heart. A large collaborative analysis published in Circulation found they reduce cardiovascular death by 14% and death from any cause by 12%, regardless of whether the patient has diabetes.
That last point is key. The benefits hold up across a remarkably wide range of patients: people with and without diabetes, people with and without prior heart failure, and people with varying levels of kidney function. For anyone living with heart failure, SGLT2 inhibitors are now a cornerstone of treatment alongside older therapies. They reduce hospitalizations and help people feel better day to day by easing fluid overload and the breathlessness and swelling that come with it.
Beta-Blockers After a Heart Attack
Beta-blockers slow the heart rate and reduce the force of each heartbeat, which lowers the heart’s demand for oxygen. For decades, they were considered essential after a heart attack. Early trials showed they reduced death by 26% to 42% in the months and years following the event.
However, the landscape has shifted. Those landmark trials were conducted before modern treatments like emergency stent placement became routine. In the current era, where most heart attack patients receive rapid blood flow restoration, newer randomized trials have not found a survival benefit from long-term beta-blocker use. They’re still commonly prescribed, particularly for people whose heart muscle was significantly weakened by the attack, but the blanket recommendation for everyone after a heart attack is no longer as firm as it once was.
GLP-1 Medications
GLP-1 receptor agonists, the same class of drugs that includes the well-known weight loss and diabetes medications, have proven cardiovascular benefits. Across eight major cardiovascular outcomes trials, these drugs reduced the combined risk of cardiovascular death, heart attack, and stroke by 14% in people with type 2 diabetes. The effect is thought to come from multiple pathways: reduced inflammation, lower blood sugar, weight loss, and improvements in blood pressure and cholesterol.
These medications are currently approved for people with type 2 diabetes and established heart disease or high cardiovascular risk. Research is ongoing to determine whether the heart benefits extend to people without diabetes, but for now, they represent an important option for the millions of people managing both diabetes and heart risk.
Low-Dose Aspirin
Aspirin prevents blood clots from forming by making platelets less sticky, and it’s a proven therapy for people who have already had a heart attack or stroke. For primary prevention, though, the picture is more complicated. The U.S. Preventive Services Task Force recommends against starting daily aspirin for anyone 60 or older who hasn’t already had a cardiovascular event, because the bleeding risk outweighs the benefit at that age.
For adults aged 40 to 59 with a 10-year cardiovascular risk of 10% or higher, aspirin is a conversation to have individually, weighing the modest reduction in heart attacks against the increased chance of stomach or intestinal bleeding. If aspirin is appropriate, the typical preventive dose is 81 mg per day.
Why the “Best” Medicine Varies
Heart disease isn’t one condition. It’s an umbrella covering clogged arteries, high blood pressure, weakened heart muscle, irregular rhythms, and more. Someone with high blood pressure and no other risk factors may only need an ARB. Someone recovering from a heart attack with a weakened heart might take a beta-blocker, a statin, an SGLT2 inhibitor, and aspirin simultaneously. The medications listed here each target a different piece of the puzzle, and for many people, the best protection comes from the right combination rather than any single pill.
What every major guideline agrees on is that medication works best on top of the basics: regular physical activity, a diet rich in vegetables, fruits, whole grains, and healthy fats, maintaining a healthy weight, not smoking, and managing stress. No pill fully compensates for the absence of those habits, and no lifestyle change fully replaces what the right medication can do for someone at genuine risk.